Annual Accounts Receivable
$676.35 M
+$43.57 M+6.89%
December 31, 2022
Summary
- As of February 7, 2025, HZNP annual accounts receivable is $676.35 million, with the most recent change of +$43.57 million (+6.89%) on December 31, 2022.
- During the last 3 years, HZNP annual accounts receivable has risen by +$267.66 million (+65.49%).
Performance
HZNP Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$717.42 M
+$92.72 M+14.84%
June 30, 2023
Summary
- As of February 7, 2025, HZNP quarterly accounts receivable is $717.42 million, with the most recent change of +$92.72 million (+14.84%) on June 30, 2023.
- Over the past year, HZNP quarterly accounts receivable has increased by +$44.11 million (+6.55%).
Performance
HZNP Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
HZNP Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.9% | +6.5% |
| 3 y3 years | +65.5% | +31.9% |
| 5 y5 years | +66.9% | +77.7% |
HZNP Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -6.4% | at high | -12.9% |
| 5 y | 5-year | at high | -39.6% | -7.5% | -43.0% |
| alltime | all time | at high | -100.0% | -7.5% | -100.0% |
Horizon Therapeutics Public Limited Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $717.42 M(+14.8%) |
| Mar 2023 | - | $624.70 M(-7.6%) |
| Dec 2022 | $676.35 M(+6.9%) | $676.35 M(+4.6%) |
| Sep 2022 | - | $646.39 M(-4.0%) |
| Jun 2022 | - | $673.31 M(-1.6%) |
| Mar 2022 | - | $684.51 M(+8.2%) |
| Dec 2021 | $632.77 M(-4.1%) | $632.77 M(-18.4%) |
| Sep 2021 | - | $775.37 M(+5.4%) |
| Jun 2021 | - | $735.43 M(+65.9%) |
| Mar 2021 | - | $443.17 M(-32.8%) |
| Dec 2020 | $659.70 M(+61.4%) | $659.70 M(-6.5%) |
| Sep 2020 | - | $705.90 M(+29.8%) |
| Jun 2020 | - | $543.75 M(+27.8%) |
| Mar 2020 | - | $425.40 M(+4.1%) |
| Dec 2019 | $408.69 M(-12.1%) | $408.69 M(+3.0%) |
| Sep 2019 | - | $396.63 M(+0.4%) |
| Jun 2019 | - | $395.02 M(-2.2%) |
| Mar 2019 | - | $403.86 M(-13.1%) |
| Dec 2018 | $464.73 M(+14.7%) | $464.73 M(+18.8%) |
| Sep 2018 | - | $391.12 M(-3.1%) |
| Jun 2018 | - | $403.67 M(-0.1%) |
| Mar 2018 | - | $404.21 M(-0.2%) |
| Dec 2017 | $405.21 M(+32.5%) | $405.21 M(+3.7%) |
| Sep 2017 | - | $390.68 M(-0.0%) |
| Jun 2017 | - | $390.84 M(-1.5%) |
| Mar 2017 | - | $396.79 M(+29.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $305.73 M(+45.3%) | $305.73 M(-15.8%) |
| Sep 2016 | - | $362.90 M(+19.2%) |
| Jun 2016 | - | $304.38 M(+4.9%) |
| Mar 2016 | - | $290.29 M(+37.9%) |
| Dec 2015 | $210.44 M(+184.7%) | $210.44 M(-4.8%) |
| Sep 2015 | - | $221.09 M(+20.9%) |
| Jun 2015 | - | $182.87 M(+43.7%) |
| Mar 2015 | - | $127.27 M(+72.2%) |
| Dec 2014 | $73.92 M(+363.2%) | $73.92 M(-7.6%) |
| Sep 2014 | - | $80.02 M(+54.5%) |
| Jun 2014 | - | $51.79 M(+29.2%) |
| Mar 2014 | - | $40.10 M(+151.3%) |
| Dec 2013 | $15.96 M(+360.8%) | $15.96 M(-4.3%) |
| Sep 2013 | - | $16.68 M(+127.2%) |
| Jun 2013 | - | $7.34 M(-4.1%) |
| Mar 2013 | - | $7.65 M(+120.9%) |
| Dec 2012 | $3.46 M(+46.0%) | $3.46 M(-42.1%) |
| Sep 2012 | - | $5.98 M(+861.3%) |
| Jun 2012 | - | $622.00 K(-21.0%) |
| Mar 2012 | - | $787.00 K(-66.8%) |
| Dec 2011 | $2.37 M(+312.5%) | $2.37 M(+812.3%) |
| Sep 2011 | - | $260.00 K(+1757.1%) |
| Jun 2011 | - | $14.00 K(-99.5%) |
| Mar 2011 | - | $2.59 M(+351.1%) |
| Dec 2010 | $575.00 K(>+9900.0%) | $575.00 K(-68.1%) |
| Sep 2010 | - | $1.80 M(>+9900.0%) |
| Dec 2009 | $0.00 | $0.00 |
FAQ
- What is Horizon Therapeutics Public Limited annual accounts receivable?
- What is the all time high annual accounts receivable for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual accounts receivable year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly accounts receivable year-on-year change?
What is Horizon Therapeutics Public Limited annual accounts receivable?
The current annual accounts receivable of HZNP is $676.35 M
What is the all time high annual accounts receivable for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual accounts receivable is $676.35 M
What is Horizon Therapeutics Public Limited annual accounts receivable year-on-year change?
Over the past year, HZNP annual accounts receivable has changed by +$43.57 M (+6.89%)
What is Horizon Therapeutics Public Limited quarterly accounts receivable?
The current quarterly accounts receivable of HZNP is $717.42 M
What is the all time high quarterly accounts receivable for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly accounts receivable is $775.37 M
What is Horizon Therapeutics Public Limited quarterly accounts receivable year-on-year change?
Over the past year, HZNP quarterly accounts receivable has changed by +$44.11 M (+6.55%)